CNE100006KG8
CNE100006KG8
CHONGQING GENRIX BIOPHARMACEUTI
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 230.726.830 | 30.094.961 | 666.7% |
| Cost of Revenue | 16.093.662 | 5.309.828 | 203.1% |
| Gross Profit | 214.633.167 | 24.785.133 | 766.0% |
| 760.198.009 | 860.696.504 | 11.7% | |
| Operating Income | -545.564.842 | -835.911.371 | 34.7% |
| Pretax Income | -535.649.615 | -797.273.630 | 32.8% |
| Net Income Common Stockholders | -535.649.615 | -797.273.630 | 32.8% |
| -- | -- | -- | |
| -- | -- | -- |